MENU
+Compare
ZTS
Stock ticker: NYSE
AS OF
Dec 3, 04:59 PM (EDT)
Price
$122.54
Change
-$1.90 (-1.53%)
Capitalization
56.08B

ZTS ZOETIS Forecast, Technical & Fundamental Analysis

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals... Show more

ZTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ZTS with price predictions
Dec 02, 2025

ZTS's Indicator enters downward trend

The Aroon Indicator for ZTS entered a downward trend on December 01, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 178 similar instances where the Aroon Indicator formed such a pattern. In of the 178 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZTS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ZTS broke above its upper Bollinger Band on November 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ZTS's RSI Indicator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 21, 2025. You may want to consider a long position or call options on ZTS as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ZTS just turned positive on November 24, 2025. Looking at past instances where ZTS's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ZTS advanced for three days, in of 312 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.163) is normal, around the industry mean (17.270). P/E Ratio (20.949) is within average values for comparable stocks, (72.547). Projected Growth (PEG Ratio) (2.336) is also within normal values, averaging (1.951). Dividend Yield (0.016) settles around the average of (0.030) among similar stocks. P/S Ratio (5.921) is also within normal values, averaging (55.439).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ZTS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
ZTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ZTS is expected to report earnings to fall 17.06% to $1.41 per share on February 17

ZOETIS ZTS Stock Earnings Reports
Q4'25
Est.
$1.41
Q3'25
Beat
by $0.08
Q2'25
Beat
by $0.14
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.02
The last earnings report on November 04 showed earnings per share of $1.70, beating the estimate of $1.62. With 1.82M shares outstanding, the current market capitalization sits at 56.08B.
A.I.Advisor
published Dividends

ZTS paid dividends on December 02, 2025

ZOETIS ZTS Stock Dividends
А dividend of $0.50 per share was paid with a record date of December 02, 2025, and an ex-dividend date of October 31, 2025. Read more...
A.I. Advisor
published General Information

General Information

a pet medication company

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
10 Sylvan Way
Phone
+1 973 822-7000
Employees
14100
Web
https://www.zoetis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LGH62.230.24
+0.39%
HCM Defender 500 Index ETF
PSFM31.530.11
+0.36%
Pacer Swan SOS Flex (April) ETF
EJUL29.270.02
+0.07%
Innovator Emerging Power Bffr ETF July
SPYD43.32-0.34
-0.78%
State Street SPDR Port S&P 500 HiDivETF
BABO14.68-0.21
-1.41%
YieldMax BABA Option Income Strategy ETF

ZTS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with ELAN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-2.21%
ELAN - ZTS
44%
Loosely correlated
-0.57%
VTRS - ZTS
39%
Loosely correlated
+0.09%
PAHC - ZTS
38%
Loosely correlated
-0.20%
PRGO - ZTS
36%
Loosely correlated
-1.73%
HLN - ZTS
35%
Loosely correlated
-1.33%
More

Groups containing ZTS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-2.21%
Pharmaceuticals: Generic
industry (213 stocks)
38%
Loosely correlated
+0.76%